Date | Company Name | Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|---|
Dec 6, 2022 | Entact Bio | Series A | — | Biopharma | — |
Dec 5, 2022 | Karyopharm Therapeutics | Post-IPO Equity | — | Health Care | — |
Jan 25, 2022 | Metagenomi | Series B | — | Artificial Intelligence | — |
Oct 7, 2021 | Science 37 | Post-IPO Equity | — | Biotechnology | — |
Oct 7, 2021 | Neumora Therapeutics | Series A | — | Biotechnology | — |
Jul 13, 2021 | Nimbus Therapeutics | Series Unknown | — | Biotechnology | — |
Apr 29, 2021 | Forge Biologics | Series B | — | Biotechnology | — |
Mar 22, 2021 | Aura Biosciences | Series Unknown | — | Biotechnology | Yes |
Jan 19, 2021 | Verve Therapeutics | Series B | — | Biotechnology | — |
Jan 7, 2021 | Scorpion Therapeutics | Series B | — | Biotechnology | — |
Sep 28, 2020 | BioShin | Series A | — | Biotechnology | — |